Skip to main content

MoneyWorks4Me

Granules India informs about press release

30 Dec 2021 Evaluate

Granules India has informed that it enclosed the press release on December 30,2021 titled ‘Granules Pharmaceuticals, Inc. Receives ANDA Approval for Amphetamine Mixed Salts (IR Tablets)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..